Chronic myeloid leukemia stem cells: targeting therapeutic implications
Abstract Chronic myeloid leukemia (CML) is a clonal myeloproliferative neoplasm driven by BCR-ABL1 oncoprotein, which plays a pivotal role in CML pathology, diagnosis, and treatment as confirmed by the success of tyrosine kinase inhibitor (TKI) therapy. Despite advances in the development of more po...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2021-12-01
|
| Reeks: | Stem Cell Research & Therapy |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s13287-021-02659-1 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|